Menu

Adherence to rivaroxaban, dabigatran, and apixaban for stroke prevention in incident, treatment-na\"\ive nonvalvular atrial fibrillation


Journal article


Joshua D Brown, Anand R Shewale, Jeffery C Talbert
Journal of managed care \& specialty pharmacy, vol. 22, Academy of Managed Care Pharmacy, 2016, pp. 1319--1329

Cite

Cite

APA   Click to copy
Brown, J. D., Shewale, A. R., & Talbert, J. C. (2016). Adherence to rivaroxaban, dabigatran, and apixaban for stroke prevention in incident, treatment-na{\"\i}ve nonvalvular atrial fibrillation. Journal of Managed Care \&Amp; Specialty Pharmacy, 22, 1319–1329.


Chicago/Turabian   Click to copy
Brown, Joshua D, Anand R Shewale, and Jeffery C Talbert. “Adherence to Rivaroxaban, Dabigatran, and Apixaban for Stroke Prevention in Incident, Treatment-Na{\&Quot;\i}Ve Nonvalvular Atrial Fibrillation.” Journal of managed care \& specialty pharmacy 22 (2016): 1319–1329.


MLA   Click to copy
Brown, Joshua D., et al. “Adherence to Rivaroxaban, Dabigatran, and Apixaban for Stroke Prevention in Incident, Treatment-Na{\&Quot;\i}Ve Nonvalvular Atrial Fibrillation.” Journal of Managed Care \&Amp; Specialty Pharmacy, vol. 22, Academy of Managed Care Pharmacy, 2016, pp. 1319–29.


BibTeX   Click to copy

@article{brown2016a,
  title = {Adherence to rivaroxaban, dabigatran, and apixaban for stroke prevention in incident, treatment-na{\"\i}ve nonvalvular atrial fibrillation},
  year = {2016},
  journal = {Journal of managed care \& specialty pharmacy},
  pages = {1319--1329},
  publisher = {Academy of Managed Care Pharmacy},
  volume = {22},
  author = {Brown, Joshua D and Shewale, Anand R and Talbert, Jeffery C}
}


Share



Follow this website


You need to create an Owlstown account to follow this website.


Sign up

Already an Owlstown member?

Log in